Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;26(30):2100673.
doi: 10.2807/1560-7917.ES.2021.26.30.2100673.

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021

Affiliations

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021

Inge Kroidl et al. Euro Surveill. 2021 Jul.

Abstract

A breakthrough infection occurred in a fully Comirnaty (BNT162b2) vaccinated healthcare worker with high levels of neutralising antibodies with the SARS-CoV-2 B.1.351 (Beta) variant in February 2021. The infection was subsequently transmitted to their unvaccinated spouse. Sequencing revealed an identical virus in both spouses, with a match of all nine single nucleotide polymorphisms typical for B.1.351. To the best of our knowledge, no transmission of any variant of SARS-CoV-2 from a fully vaccinated person has been described before.

Keywords: B.1.351; SARS-CoV-2; breakthrough infection; transmission; unvaccinated partner; vaccination.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure
Figure
Timeline of events in a case of breakthrough infection in a fully vaccinated HCW and onward transmission of SARS-CoV-2 Beta (B.1.351) variant to unvaccinated spouse, Bavaria, Germany, February to March 2021

References

    1. World Health Organization (WHO). Tracking SARS-CoV-2 variants. Geneva: WHO. [Accessed: 25 Jul 2021]. Available from: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants.
    1. Tegally H, Wilkinson E, Lessells RJ, Giandhari J, Pillay S, Msomi N, et al. Sixteen novel lineages of SARS-CoV-2 in South Africa. Nat Med. 2021;27(3):440-6. 10.1038/s41591-021-01255-3 - DOI - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-15. 10.1056/NEJMoa2034577 - DOI - PMC - PubMed
    1. Eberle U, Heinzinger S, Konrad R, Wimmer C, Liebl B, Katz K, et al. Virological COVID-19 surveillance in Bavaria, Germany suggests no SARS-CoV-2 spread prior to the first German case in January 2020. Infection. 2021. 10.1007/s15010-021-01611-y - DOI - PMC - PubMed
    1. Quick J. nCoV-2019 sequencing protocol V.1. Berkeley: protocols.io. 22 Jan 2020. Available from: https://www.protocols.io/view/ncov-2019-sequencing-protocol-bbmuik6w?ver...

Publication types